These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 26203636)

  • 1. Unprocessed Interleukin-36α Regulates Psoriasis-Like Skin Inflammation in Cooperation With Interleukin-1.
    Milora KA; Fu H; Dubaz O; Jensen LE
    J Invest Dermatol; 2015 Dec; 135(12):2992-3000. PubMed ID: 26203636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-36α from Skin-Resident Cells Plays an Important Role in the Pathogenesis of Imiquimod-Induced Psoriasiform Dermatitis by Forming a Local Autoamplification Loop.
    Hashiguchi Y; Yabe R; Chung SH; Murayama MA; Yoshida K; Matsuo K; Kubo S; Saijo S; Nakamura Y; Matsue H; Iwakura Y
    J Immunol; 2018 Jul; 201(1):167-182. PubMed ID: 29794016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
    Boutet MA; Bart G; Penhoat M; Amiaud J; Brulin B; Charrier C; Morel F; Lecron JC; Rolli-Derkinderen M; Bourreille A; Vigne S; Gabay C; Palmer G; Le Goff B; Blanchard F
    Clin Exp Immunol; 2016 May; 184(2):159-73. PubMed ID: 26701127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Chemokine Receptor Inhibition in Treating IL-36α-Induced Psoriasiform Inflammation.
    Campbell JJ; Ebsworth K; Ertl LS; McMahon JP; Wang Y; Yau S; Mali VR; Chhina V; Kumamoto A; Liu S; Dang T; Newland D; Charo IF; Zhang P; Schall TJ; Singh R
    J Immunol; 2019 Mar; 202(6):1687-1692. PubMed ID: 30718298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-36 receptor antagonistic antibodies inhibit inflammatory responses in preclinical models of psoriasiform dermatitis.
    Su Z; Paulsboe S; Wetter J; Salte K; Kannan A; Mathew S; Horowitz A; Gerstein C; Namovic M; Todorović V; Seagal J; Edelmayer RM; Viner M; Rinaldi L; Zhou L; Leys L; Huang S; Wang L; Sadhukhan R; Honore P; McGaraughty S; Scott VE
    Exp Dermatol; 2019 Feb; 28(2):113-120. PubMed ID: 30417427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imiquimod Treatment Causes Systemic Disease in Mice Resembling Generalized Pustular Psoriasis in an IL-1 and IL-36 Dependent Manner.
    Alvarez P; Jensen LE
    Mediators Inflamm; 2016; 2016():6756138. PubMed ID: 28057979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-1R1 signaling facilitates Munro's microabscess formation in psoriasiform imiquimod-induced skin inflammation.
    Uribe-Herranz M; Lian LH; Hooper KM; Milora KA; Jensen LE
    J Invest Dermatol; 2013 Jun; 133(6):1541-9. PubMed ID: 23407395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of IL-36 cytokines in folliculitis and eosinophilic pustular folliculitis.
    Sato S; Chiba T; Nakahara T; Furue M
    Australas J Dermatol; 2020 Feb; 61(1):e39-e45. PubMed ID: 31424098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-36α is involved in hapten-specific T-cell induction, but not local inflammation, during contact hypersensitivity.
    Numata T; Yoshizaki T; Yamaguchi S; Shimura E; Iwakura Y; Harada K; Sudo K; Tsuboi R; Nakae S
    Biochem Biophys Res Commun; 2018 Nov; 506(3):429-436. PubMed ID: 30352688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-36α exerts pro-inflammatory effects in the lungs of mice.
    Ramadas RA; Ewart SL; Iwakura Y; Medoff BD; LeVine AM
    PLoS One; 2012; 7(9):e45784. PubMed ID: 23029241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression.
    Palomo J; Troccaz S; Talabot-Ayer D; Rodriguez E; Palmer G
    PLoS One; 2018; 13(3):e0194667. PubMed ID: 29554104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The balance between pro- and anti-inflammatory cytokines is crucial in human allergic contact dermatitis pathogenesis: the role of IL-1 family members.
    Mattii M; Ayala F; Balato N; Filotico R; Lembo S; Schiattarella M; Patruno C; Marone G; Balato A
    Exp Dermatol; 2013 Dec; 22(12):813-9. PubMed ID: 24164463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity.
    Towne JE; Renshaw BR; Douangpanya J; Lipsky BP; Shen M; Gabel CA; Sims JE
    J Biol Chem; 2011 Dec; 286(49):42594-42602. PubMed ID: 21965679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil-Derived Proteases Escalate Inflammation through Activation of IL-36 Family Cytokines.
    Henry CM; Sullivan GP; Clancy DM; Afonina IS; Kulms D; Martin SJ
    Cell Rep; 2016 Feb; 14(4):708-722. PubMed ID: 26776523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I IL-1 receptor mediates IL-1 and intracellular IL-1 receptor antagonist effects in skin inflammation.
    Palmer G; Talabot-Ayer D; Kaya G; Gabay C
    J Invest Dermatol; 2007 Aug; 127(8):1938-46. PubMed ID: 17476299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-33 induces skin inflammation with mast cell and neutrophil activation.
    Hueber AJ; Alves-Filho JC; Asquith DL; Michels C; Millar NL; Reilly JH; Graham GJ; Liew FY; Miller AM; McInnes IB
    Eur J Immunol; 2011 Aug; 41(8):2229-37. PubMed ID: 21674479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-36 in hidradenitis suppurativa: evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop.
    Hessam S; Sand M; Gambichler T; Skrygan M; Rüddel I; Bechara FG
    Br J Dermatol; 2018 Mar; 178(3):761-767. PubMed ID: 28975626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered serum levels of IL-36 cytokines (IL-36α, IL-36β, IL-36γ, and IL-36Ra) and their potential roles in Guillain-Barré syndrome.
    Zhao Z; Zhang R; Gao X; Li H; Liu H
    Medicine (Baltimore); 2020 Dec; 99(52):e23832. PubMed ID: 33350771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated sputum IL-36 levels are associated with neutrophil-related inflammation in COPD patients.
    Li W; Meng X; Hao Y; Chen M; Jia Y; Gao P
    Clin Respir J; 2021 Jun; 15(6):648-656. PubMed ID: 33559376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triptolide analog LLDT-8 ameliorates psoriasis-like dermatitis in BALB/c mice via suppressing the IL-36α signaling pathway.
    Qi Q; Li Q; Zhu H; Lu H; Yang X; Wu Y; Feng C; Fan C; Li H; Wu B; Gao Y; Zhang Z; Zhou H; Zuo J; Tang W
    Pharmacol Res; 2021 Jul; 169():105678. PubMed ID: 34015449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.